Literature DB >> 18611362

Lessons learned from the CRUSADE National Quality Improvement Initiative.

Eric D Peterson1, David Z Bynum, Matthew T Roe.   

Abstract

The CRUSADE National Quality Improvement Initiative was created to track national care patterns, facilitate process improvement, and improve patient outcomes among patients with acute coronary syndromes (ACS). CRUSADE found that patients in community practice were sicker than those in randomized clinical trials and often failed to receive evidence-based therapies. Dosing regimens of antithrombotic therapy were also suboptimal, raising safety concerns. Over time, guideline adherence and dosing regimens of ACS patients have improved dramatically, leading to significantly improved outcomes. Ongoing quality improvement efforts will be needed to further improve evidence-based and personalized care of patients with ACS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18611362     DOI: 10.1007/s11886-008-0046-9

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  38 in total

1.  Insurance coverage and care of patients with non-ST-segment elevation acute coronary syndromes.

Authors:  James E Calvin; Matthew T Roe; Anita Y Chen; Rajendra H Mehta; Gerard X Brogan; Elizabeth R Delong; Dan J Fintel; W Brian Gibler; E Magnus Ohman; Sidney C Smith; Eric D Peterson
Journal:  Ann Intern Med       Date:  2006-11-21       Impact factor: 25.391

2.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

3.  Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative.

Authors:  Andra L Blomkalns; Anita Y Chen; Judith S Hochman; Eric D Peterson; Kelly Trynosky; Deborah B Diercks; Gerard X Brogan; William E Boden; Matthew T Roe; E Magnus Ohman; W Brian Gibler; L Kristin Newby
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

4.  Prognostic value of the admission electrocardiogram in acute coronary syndromes.

Authors:  S Savonitto; D Ardissino; C B Granger; G Morando; M D Prando; A Mafrici; C Cavallini; G Melandri; T D Thompson; A Vahanian; E M Ohman; R M Califf; F Van de Werf; E J Topol
Journal:  JAMA       Date:  1999-02-24       Impact factor: 56.272

5.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.

Authors:  L Wallentin; B Lagerqvist; S Husted; F Kontny; E Ståhle; E Swahn
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

6.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

7.  Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.

Authors:  Karen P Alexander; Anita Y Chen; Matthew T Roe; L Kristin Newby; C Michael Gibson; Nancy M Allen-LaPointe; Charles Pollack; W Brian Gibler; E Magnus Ohman; Eric D Peterson
Journal:  JAMA       Date:  2005-12-28       Impact factor: 56.272

8.  Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.

Authors:  Jin H Han; Abhinav Chandra; Jyotsna Mulgund; Matthew T Roe; Eric D Peterson; Lynda A Szczech; Uptal Patel; E Magnus Ohman; Christopher J Lindsell; W Brian Gibler
Journal:  Am J Med       Date:  2006-03       Impact factor: 4.965

9.  Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative.

Authors:  Adam H Skolnick; Karen P Alexander; Anita Y Chen; Matthew T Roe; Charles V Pollack; E Magnus Ohman; John S Rumsfeld; W Brian Gibler; Eric D Peterson; David J Cohen
Journal:  J Am Coll Cardiol       Date:  2007-04-16       Impact factor: 24.094

10.  Pay for performance, quality of care, and outcomes in acute myocardial infarction.

Authors:  Seth W Glickman; Fang-Shu Ou; Elizabeth R DeLong; Matthew T Roe; Barbara L Lytle; Jyotsna Mulgund; John S Rumsfeld; W Brian Gibler; E Magnus Ohman; Kevin A Schulman; Eric D Peterson
Journal:  JAMA       Date:  2007-06-06       Impact factor: 56.272

View more
  1 in total

Review 1.  Balancing the benefits and risks of antiplatelet agents in patients with non-ST-segment elevated acute coronary syndromes and undergoing percutaneous coronary intervention.

Authors:  Jorge F Saucedo
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.